HPVC2026-058: Pharmaceutical Products
Current Contract
Contract start date: 30 Jan 2026
Contract end date: 28 Feb 2029
Option periods: 2 x 2yrs
Description
Contract for the provision of a range of pharmaceutical products to Victorian public health services.Additional information
Update: 21st of July 2026
HPVITS2026-058.001 Pharmaceutical Products (Supplementary 001) – Outcome
HSV has completed Supplementary 001 under the Pharmaceutical Products contract (HPVC2026-058), adding three categories – Ferric Carboxymaltose, Isavuconazole and Tocilizumab – following a competitive tender process. The contract commences on 1 August 2026.
For further details of the awarded products and pricing, please refer to the Award Matrix and Pricing Schedule.